Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication

Ghashghaeinia, Mehrdad; Dreischer, Peter; Wieder, Thomas; Koeberle, Martin

dc.contributor.author	Ghashghaeinia, Mehrdad
dc.contributor.author	Dreischer, Peter
dc.contributor.author	Wieder, Thomas
dc.date.accessioned	2021-03-29T09:55:01Z
dc.date.available	2021-03-29T09:55:01Z
dc.date.issued	2020
dc.identifier.issn	1551-4005
dc.identifier.uri	http://hdl.handle.net/10900/113762
dc.language.iso	en	en
dc.publisher	Taylor & Francis Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/15384101.2020.1859197
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_00152
utue.publikation.seiten	3399-3405	de_DE
utue.personen.roh	Ghashghaeinia, Mehrdad
utue.personen.roh	Dreischer, Peter
utue.personen.roh	Wieder, Thomas
utue.personen.roh	Koeberle, Martin
dcterms.isPartOf.ZSTitelID	Cell Cycle	de_DE
dcterms.isPartOf.ZS-Issue	24	de_DE
dcterms.isPartOf.ZS-Volume	19	de_DE
utue.fakultaet	04 Medizinische Fakultät